about
Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporterCervical lymph node diseases in childrenTangier disease: epidemiology, pathophysiology, and management.Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunctionLecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.Apolipoprotein mimetic peptides: a new approach for the treatment of asthma.Sterol transport in yeast and the oxysterol binding protein homologue (OSH) familyDiseases of intramembranous lipid transport.High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol.Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases.Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides."Who's on first": determining the roster for the key players in the reverse cholesterol transport pathway.Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease.HDL and cholesterol: life after the divorce?Macrophage-related diseases of the gut: a pathologist's perspective.Cholesterol efflux to apoA-I in ABCA1-expressing cells is regulated by Ca2+-dependent calcineurin signaling.ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments.[HDL: the yin-yang of cardiovascular disease].ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells.Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia.
P2860
Q24302387-BB4E09D1-FA73-427F-8867-8F34E5B38DDDQ26865114-1998DDE6-3BF4-4DFC-BBBB-1B80698BD27BQ33402921-B0072707-544B-4008-BDF5-FF9A26AAF6E2Q33751570-071E4C2B-B418-4B81-89BB-7B3A64932552Q34021570-104A8AD4-C940-4AF6-B763-CB1777DE2D2FQ34051644-6563F88B-8D9F-4175-B5FA-88021C7B8828Q34181607-14877267-F1DC-471E-AC9F-5D0E40B5F982Q34594140-F87D1A95-0132-4422-93EB-2AD30723864FQ35815986-8CBD6058-DE1C-4A4C-AD2A-F3B58FE78E5FQ36082960-5B284404-C810-4706-9147-59805B0E2EBDQ36530456-68EC43A5-92BC-4689-982F-87DE0FB3003FQ36607325-B705EA84-4DA3-4473-9A85-0D84AA89F2EDQ36841990-24E97B65-549A-4BD5-8CFD-13EEF77D6172Q36973725-89069846-110D-4668-A62D-EF7E23ED9A08Q37211062-458B0E55-852F-451B-AA79-2D46FCE46D16Q37224981-7D823578-B02D-4D4A-A2AA-A3F1F558E6EEQ37302183-A46C9461-CDDC-4D2D-BA0F-2278AC6FBEECQ37576357-1FEC9E50-1E52-4016-B2B7-787FDBA2F27AQ37590250-D0A3F03F-8967-4BF6-B5C9-DCB418597D22Q38009240-327226A6-662E-4E51-8804-27D8D745CED2Q39766436-FAC8AF6E-1E15-40BB-9E3B-E36572E5BF86Q39926840-C57EB83E-7CE9-4934-892B-47CEF96C633FQ39995605-10A4CC7D-3042-40F0-8BA1-B2DC90566BD9Q42749585-53809323-8D41-4807-AED2-80A14E6BD2A6Q45967296-56FB0B76-4885-4CC1-8579-8150E919DD0AQ48486252-F6A34A9A-E1F9-4331-BD41-63713B828D54
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tangier disease: still more questions than answers
@ast
Tangier disease: still more questions than answers
@en
Tangier disease: still more questions than answers
@nl
type
label
Tangier disease: still more questions than answers
@ast
Tangier disease: still more questions than answers
@en
Tangier disease: still more questions than answers
@nl
prefLabel
Tangier disease: still more questions than answers
@ast
Tangier disease: still more questions than answers
@en
Tangier disease: still more questions than answers
@nl
P1476
Tangier disease: still more questions than answers
@en
P2093
A T Remaley
P2888
P304
P356
10.1007/S00018-005-5125-0
P407
P577
2005-10-01T00:00:00Z